Malalties hepàtiques víriques, genètiques i immuno-mediades
Publicacions destacades
-
Hepatitis D double reflex testing of all hepatitis B carriers in low HBV and high HBV/high HDV prevalence countries
Razavi, Homie A; Buti, Maria; Terrault, Norah A; Zeuzem, Stefan; Yurdaydin, Cihan;(...)Villalobos-Salcedo, Juan Miguel; Voeller, Alexis S; Yang, Hwai-, I; Yu, Ming-Lung; Zuckerman, Eli.Referència:Journal Of Hepatology 2023.
-
Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predni(so)lone administration
Díaz-González, A; Hernández-Guerra, M; Pérez-Medrano, I; Sapena, V; Riveiro-Barciela, M;(...)López, C; Alvarez-Navascúes, C; García-Retortillo, M; Crespo, J; Londoño, MC.Referència:Hepatology 2023.
-
Tissue CD14+CD8+ T cells reprogrammed by myeloid cells and modulated by LPS
Pallett, LJ; Swadling, L; Diniz, M; Maini, AA; Schwabenland, M;(...)Gilroy, DW; Dorner, M; Bengsch, B; Schurich, A; Maini, MK.Referència:Nature 2023.
-
Non-invasive tests for clinically significant portal hypertension after HCV cure
Semmler, Georg; Lens, Sabela; Meyer, Elias L; Baiges, Anna; Alvardo-Tapias, Edilmar;(...)Hernandez-Gea, Virginia; Reiberger, Thomas; Bosch, Jaume; Pagan, Juan Carlos Garcia; Mandorfer, Mattias.Referència:Journal Of Hepatology 2022.
-
Liver cancer risk after HCV cure in patients with advanced liver disease without non-characterized nodules
Sanduzzi-Zamparelli, Marco; Marino, Zoe; Lens, Sabela; Sapena, Victor; Iserte, Gemma;(...)Forner, Alejandro; Torres, Ferran; Bruix, Jordi; Forns, Xavier; Reig, Maria.Referència:Journal Of Hepatology 2022.
-
Off-therapy response after nucleos(t)ide analogue withdrawal in patients with chronic hepatitis B: An international, multi-center, multi-ethnic cohort (RETRACT-B study)
Hirode, G; Choi, HSJ; Chen, CH; Su, TH; Seto, WK;(...)Kao, JH; Cornberg, M; Hansen, BE; Jeng, WJ; Janssen, HLA.Referència:Gastroenterology 2022.
-
Quantification of polyreactive immunoglobulin G facilitates the diagnosis of autoimmune hepatitis
Taubert, R; Engel, B; Diestelhorst, J; Hupa-Breier, KL; Behrendt, P;(...)Maasoumy, B; Witte, T; Wedemeyer, H; Manns, MP; Jaeckel, E.Referència:Hepatology 2022.
-
Viral and immune factors associated with successful treatment withdrawal in HBeAg-negative chronic hepatitis B patients
Garcia-Lopez, Mireia; Lens, Sabela; Pallett, Laura J; Testoni, Barbara; Rodriguez-Tajes, Sergio;(...)Koutsoudakis, George; Zoulim, Fabien; Maini, Mala K; Forns, Xavier; Perez-del-Pulgar, Sofia.Referència:Journal Of Hepatology 2021.
-
Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension
Lens, Sabela; Baiges, Anna; Alvarado-Tapias, Edilmar; LLop, Elba; Martinez, Javier;(...)Hernandez-Gea, Virginia; Bosch, Jaume; Villanueva, Candid; Carlos Garcia-Pagan, Juan; Forns, Xavier.Referència:Journal Of Hepatology 2020.
-
Hepatitis C-related cirrhosis will be a marginal cause of hospital admissions in the near future
Rodriguez-Tajes, Sergio; Pocurull, Anna; Castillo, Joaquin; Casanova, Gherzon; Vega, Laia;(...)Marino, Zoe; Londono, Maria-Carlota; Forner, Alejandro; Torres, Ferran; Forns, Xavier.Referència:Journal Of Hepatology 2020.